NCT02730819View on ClinicalTrials.gov

Topical Composition Therapy (2013-MCN-333) for the Treatment of Melasma

PHASE2CompletedINTERVENTIONAL

Enrollment

19

Participants

Timeline

Start Date

May 15, 2016

Primary Completion Date

December 30, 2016

Study Completion Date

December 30, 2016

Conditions

Melasma

Interventions

DRUG

Illuminate Cream

Topical compound applied daily

Trial Locations (1)

32224

Mayo Clinic in Florida, Jacksonville

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Mayo Clinic

OTHER